Mabwell (Shanghai) Bioscience Co., Ltd. is a biopharmaceutical company, which engages in the research and development, manufacturing, and commercialization of therapeutic biological products. The firm's platform covers antibody drug discovery, pharmaceutical development, quality research control and assurance, medical and clinical operations, and commercial base. It operates through the Mainland China and Overseas geographical segments. The company was founded by Chun Shan Tang on May 12, 2017 and is headquartered in Shanghai, China.